Share on StockTwits

Acceleron Pharma (NASDAQ:XLRN) SVP Matthew L. Sherman unloaded 7,500 shares of the stock in a transaction dated Wednesday, June 11th. The stock was sold at an average price of $33.23, for a total transaction of $249,225.00. Following the completion of the sale, the senior vice president now directly owns 15,858 shares of the company’s stock, valued at approximately $526,961. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Shares of Acceleron Pharma (NASDAQ:XLRN) traded down 1.05% on Friday, hitting $33.88. The stock had a trading volume of 289,137 shares. Acceleron Pharma has a 52-week low of $16.78 and a 52-week high of $57.89. The stock has a 50-day moving average of $31.84 and a 200-day moving average of $37.60. The company’s market cap is $1.066 billion.

Acceleron Pharma (NASDAQ:XLRN) last posted its quarterly earnings results on Thursday, May 15th. The company reported ($0.30) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.44) by $0.14. The company had revenue of $3.31 million for the quarter, compared to the consensus estimate of $2.85 million. Analysts expect that Acceleron Pharma will post $-1.24 EPS for the current fiscal year.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.